ClinicalTrials.Veeva

Menu

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block

S

Sohag University

Status

Enrolling

Conditions

İnguinal Hernia

Treatments

Drug: Dexamethasone
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT07056244
soh-Med-25-6-13MS

Details and patient eligibility

About

The goal of This prospective, randomized, double-blind comparative study is to compare the efficacy of dexamethasone and dexmedetomidine as adjuvants to bupivacaine 0.125% in caudal epidural block for pediatrics undergoing inguinal hernia surgery, aged 2-6 years.

of Both sex.

Enrollment

80 estimated patients

Sex

All

Ages

2 to 6 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children aged 2-6 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Scheduled for inguinal hernia surgery

Exclusion criteria

  • Parents or legal guardians refusal.
  • Known hypersensitivity to any study drugs.
  • Abnormal sacral anatomy
  • Local infection at the injection site.
  • Neurological disease.
  • Coagulopathy.
  • Mental retardation.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

group A will receive Bupivacaine + Dexmedetomidine
Active Comparator group
Description:
Patients will receive Bupivacaine 0.125% at 0.5 ml/kg + Dexmedetomidine 1.5 mcg/kg for post operative analgesia.
Treatment:
Drug: Dexmedetomidine
group B will receive Bupivacaine + Dexamethasone
Active Comparator group
Description:
Patients will receive Bupivacaine 0.125% at 0.5 ml/kg + Dexamethasone 0.2 mg/kg for post operative analgesia.
Treatment:
Drug: Dexamethasone

Trial contacts and locations

1

Loading...

Central trial contact

Hala M Hashem, assistant professor; Reham R Younis, resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems